RXRX

RECURSION PHARMACEUTICALS IN

RXRX·75629V104·US·Common Stock·Healthcare - Biotechnology-Activist

RXRX (RECURSION PHARMACEUTICALS IN) is held by 159 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($132.6M), ARK Investment Management LLC ($123.5M), STATE STREET CORP ($87.5M). Net institutional sentiment: Mixed.

159
Holders
(32 Elite)
$909.8M
Total Value
59% (164)
Consensus
97 buying - 67 selling
13F: Insider & Congress:
RXRXSmart Money Verdict
View all
Held by 159 funds
32 elite
Who's Trading
InsiderBBBorgeson BlakeSell $159KJul 7, 2026
InsiderKNKhan NajatSell $84KJun 5, 2026
InsiderGCGibson ChristopherSell $145KJun 5, 2026
InsiderBNBumpus NamandjeSell $16KJun 3, 2026
InsiderBBBorgeson BlakeSell $110KJun 2, 2026
ActivistSTATE STREET CORPORATIONSTATE STREET CORPORATION5.5%May 12, 2026
InsiderGCGibson ChristopherC 60K shMay 7, 2026
InsiderGCGibson ChristopherSell $135KMay 7, 2026
InsiderGCGibson ChristopherGift 20K shMay 7, 2026
ActivistBlackRock, Inc.BlackRock, Inc.7.2%Apr 24, 2026
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
43.2M(+11.1%)$132.6M0.0%-37.16%
34
Increased
40.2M(+7.8%)$123.5M1.0%-60.63%
46
Increased
28.5M(+12.5%)$87.5M0.0%-41.57%
34
Decreased
23.7M(-0.4%)$72.7M0.1%-87.62%
0
New
22.8M$69.9M0.0%+0.56%
41
New
22.2M$68.3M0.0%+0.56%
41
Unchanged
13.6M$41.9M0.4%-47.42%
0
Increased
12.3M(+12.3%)$37.7M0.0%-56.03%
33
Increased
6.1M(+175.5%)$18.6M0.0%-16.43%
46
Decreased
5.4M(-12.9%)$16.6M0.0%-61.08%
0
Decreased
5.4M(-12.9%)$16.6M0.2%-63.92%
0
Increased
5.1M(+38.2%)$15.7M0.0%-37.44%
37
Decreased
4.2M(-3.9%)$13M0.0%-40.01%
0
Increased
4.1M(+32.2%)$12.5M0.0%-33.89%
36
Decreased
4M(-1.3%)$12.4M0.0%-44.87%
0
Increased
4M(+15.4%)$12.2M0.0%-62.69%
32
Decreased
3.8M(-4.7%)$11.7M0.0%-57.54%
0
New
3.5M$10.8M0.0%+0.56%
38
Increased
2.9M(+1169.6%)$8.8M0.0%-1.96%
44
Increased
2.6M(+74.6%)$8M0.0%-7.92%
41

Showing 1-20 of 171

1 / 9

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used